Regulation & Compliance

As Byline Bancorp nears a key $10B asset threshold, all eyes are on its Q4 results to see if its strong performance can overcome market headwinds.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

At CES 2026, PETKIT unveiled an AI ecosystem that turns feeders and litter boxes into health monitors, promising to catch illnesses in pets early.

A strategic partnership used deep learning AI to boost insurance leads by 32% and win major French awards. Here's how they did it.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

A fatal head-on train collision near Machu Picchu leaves one dead and dozens injured, triggering a massive tourist rescue operation by Peruvian authorities.

A new white paper alleges many botanical supplements lack active ingredients. Is the industry ready for a scientific overhaul to prove what's in the bottle?

NAVER D2SF invests in Sorcerics, a startup whose proactive AI and on-device processing promise a smarter, safer, and more affordable smart home future.

The revered former U.S. Senator announced his withdrawal from public life following a dementia diagnosis, ending a storied career and sparking reflection.

As thousands celebrate, a massive art installation will project faces asking if they're next for immigration raids, turning a party into a protest.

A US-based Sikh group proposes a Christian homeland in India, citing a wave of anti-Christian violence that marred Christmas 2025 celebrations.

The Faroe Islands-based oil firm pushes its critical debt restructuring deadline again, placing its future entirely on a pending deal and a single oil field.

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

As 'GLP-1 patch' ads flood social media for New Year's, an investigation reveals misleading marketing, a lack of science, and complex global companies.

A new partnership aims to create a one-stop shop for crypto firms, combining regulatory licensing with institutional-grade digital asset custody.

After 16 years, Chief Legal Officer Anthony Green announces his retirement, leaving a void at the top and questions about Annaly's future governance.

Kite Realty Group declared a special dividend for shareholders. We dig into whether this signals a healthy retail market or is simply a savvy tax strategy.